PRESS RELEASE published on 04/09/2025 at 15:30, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.38% stake in Direct Line Insurance Group plc on April 8, 2025, in compliance with Rule 8.3 of the Takeover Code Rule 8.3 Takeover Code Vanguard Group Stake Disclosure Direct Line Insurance Group
BRIEF published on 04/08/2025 at 15:52, 1 year 5 months ago Vanguard Group Discloses Position in Direct Line Insurance Group Takeover Code Securities Disclosure Vanguard Group Direct Line Insurance Aviva Plc
BRIEF published on 04/08/2025 at 15:52, 1 year 5 months ago Le groupe Vanguard révèle sa position dans Direct Line Insurance Group Groupe Vanguard Code De Prise De Contrôle Divulgation Des Valeurs Mobilières Aviva Plc Assurance Direct Line
PRESS RELEASE published on 04/08/2025 at 15:47, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.38% stake in Direct Line Insurance Group plc as of 07 April 2025 Vanguard Group Financial Disclosure Stake Disclosure Direct Line Insurance Group Stock Holdings
BRIEF published on 04/07/2025 at 15:29, 1 year 5 months ago Vanguard révèle sa position dans Direct Line Insurance Group Actionnariat Groupe Vanguard Code De Prise De Contrôle Divulgation Des Valeurs Mobilières Assurance Direct Line
BRIEF published on 04/07/2025 at 15:29, 1 year 5 months ago Vanguard Discloses Position in Direct Line Insurance Group Takeover Code Securities Disclosure Vanguard Group Shareholding Direct Line Insurance
PRESS RELEASE published on 04/07/2025 at 15:24, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses holding 5.38% stake in Direct Line Insurance Group plc. Disclosure made on 07-Apr-2025 Disclosure Vanguard Group Shareholding Stake Direct Line Insurance
BRIEF published on 04/03/2025 at 15:16, 1 year 5 months ago Participation du groupe Vanguard dans Direct Line Insurance Group Code De Prise De Contrôle Transactions Boursières Le Groupe Vanguard Divulgation Des Actions Assurance Direct Line
BRIEF published on 04/03/2025 at 15:16, 1 year 5 months ago The Vanguard Group's Stake in Direct Line Insurance Group The Vanguard Group Takeover Code Stock Transactions Shareholding Disclosure Direct Line Insurance
PRESS RELEASE published on 04/03/2025 at 15:11, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.38% stake in Direct Line Insurance Group plc. Detailed Form 8.3 submission for regulatory disclosure Form 8.3 Vanguard Group Stake Disclosure Direct Line Insurance Financial Regulatory
Published on 09/11/2026 at 04:00, 6 hours 30 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 12 hours 5 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 19 hours 10 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 19 hours 30 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 10:15, 15 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 09:20, 1 hour 10 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 1 hour 25 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 1 hour 30 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 3 hours 30 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 3 hours 30 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 3 hours 30 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
